MX9705537A - Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente. - Google Patents

Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente.

Info

Publication number
MX9705537A
MX9705537A MX9705537A MX9705537A MX9705537A MX 9705537 A MX9705537 A MX 9705537A MX 9705537 A MX9705537 A MX 9705537A MX 9705537 A MX9705537 A MX 9705537A MX 9705537 A MX9705537 A MX 9705537A
Authority
MX
Mexico
Prior art keywords
methods
environmental estrogens
inhibiting environmental
inhibiting
estrogens
Prior art date
Application number
MX9705537A
Other languages
English (en)
Other versions
MXPA97005537A (es
Inventor
Henry Uhlman Bryant
Jeffrey Alan Dodge
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9705537A publication Critical patent/MX9705537A/es
Publication of MXPA97005537A publication Critical patent/MXPA97005537A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invencion se refiere a un método para inhibir los efectos de los estrogenos del medio ambiente, que comprende la administracion a un ser humano que tenga la necesidad del mismo, de un compuesto que tiene la formula (I), en donde R1 y R2 son independientemente hidrogeno, -CH3, (a), o (b), en donde Ar es fenilo substituido opcionalmente, R2 se selecciona del grupo que consiste de pirrolidina, hexametilenimino, y piperidino, o una sal o solvato del mismo aceptable farmacéuticamente.
MXPA/A/1997/005537A 1995-01-25 1997-07-22 Metodo y composiciones para inhibir el efecto delos estrogenos del medio ambiente MXPA97005537A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08378229 1995-01-25
US08/378,229 US5521214A (en) 1995-01-25 1995-01-25 Methods of inhibiting environmental estrogens
PCT/US1996/000902 WO1996022771A1 (en) 1995-01-25 1996-01-22 Methods of inhibiting environmental estrogens

Publications (2)

Publication Number Publication Date
MX9705537A true MX9705537A (es) 1997-10-31
MXPA97005537A MXPA97005537A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
WO1996022771A1 (en) 1996-08-01
NO973367D0 (no) 1997-07-21
HUP9800550A3 (en) 1999-10-28
KR19980701589A (ko) 1998-05-15
EP0806950A4 (en) 1999-01-07
FI973095A0 (fi) 1997-07-23
CA2210940A1 (en) 1996-08-01
HUP9800550A2 (hu) 1998-12-28
EA199700136A1 (ru) 1997-12-30
NO973367L (no) 1997-07-21
CZ233797A3 (cs) 1998-02-18
AU4764996A (en) 1996-08-14
CN1169116A (zh) 1997-12-31
FI973095A (fi) 1997-07-24
EP0806950A1 (en) 1997-11-19
US5521214A (en) 1996-05-28
JPH10512886A (ja) 1998-12-08
AU699678B2 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
MY132251A (en) Methods of inhibiting cell-cell adhesion
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
AU7578794A (en) Methods for inhibiting endometriosis
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
UA27910C2 (uk) Засіб для підвищення експресії тромбомодуліну та підвищення активації протеїну с
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
MX9709466A (es) Medicamento para inhibir el melanoma.
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
MX9701333A (es) Metodos para inhibir el daño neuronal.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
MY113406A (en) Methods of inhibiting physiological conditions associated with an excess of bradykinin
MX9701332A (es) Metodos para curar y reparar fracturas oseas.
MX9701359A (es) Metodos para la inhibicion de la hiperplasia endometrial primaria.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9701328A (es) Metodos de reduccion de la cicatrizacion en la curacion de heridas.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9706520A (es) Metodos para inhibir el cancer de ovario.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.
MX9702853A (es) Metodos para inhibir condiciones asociadas con el neuropeptido "y".

Legal Events

Date Code Title Description
FA Abandonment or withdrawal